EA
JAZZ icon

Ellsworth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Ellsworth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-37,338
Closed -$4.64M – 181
2025
Q1 		$4.64M Sell
37,338
-624
-2% -$81.4K 1.22% 30
2024
Q4 		$4.68M Buy
37,962
+149
+0.4% +$17.6K 1.23% 33
2024
Q3 		$4.21M Buy
37,813
+632
+2% +$69.3K 1.09% 43
2024
Q2 		$3.97M Buy
37,181
+1,401
+4% +$154K 1.11% 42
2024
Q1 		$3.96M Buy
+35,780
New +$4.38M 1.14% 41

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Ellsworth Advisors's JAZZ Position: Q2 2025 in Review

Ellsworth Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2025, closing a stake of 37,338 shares — an estimated $4.64M sold.

Ellsworth Advisors first reported a position in JAZZ in Q1 2024 and held it in 5 quarters. The position peaked at $4.68M in Q4 2024. 502 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.

  • Ellsworth Advisors reported no remaining Jazz Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Ellsworth Advisors sold 37,338 Jazz Pharmaceuticals shares in Q2 2025, an estimated $4.64M.
  • Ellsworth Advisors first reported a position in Jazz Pharmaceuticals in Q1 2024 and held it in 5 quarters.
  • Ellsworth Advisors's Jazz Pharmaceuticals position peaked at $4.68M in Q4 2024.
  • 502 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.

Based on Ellsworth Advisors's 13F filing for Q2 2025, filed 23 Jul 2025.